How Fast Do Aneurysms Grow and When Are They Dangerous?

Learn how aneurysm size and growth are tracked, which factors accelerate progression, and the critical link between rate and rupture risk.

Most aneurysms grow slowly, on the order of one to three millimeters per year, though the rate varies widely depending on where the aneurysm sits, how large it already is, and who is carrying it. That modest-sounding pace is deceptive. Growth is not steady or predictable, and the relationship between size and danger is more complicated than a single threshold number. The science of aneurysm surveillance has evolved considerably over the past two decades, and much of what determines “dangerous” now involves factors well beyond diameter alone.

Typical Growth Rates by Location

Aneurysms in different arteries behave differently, so there is no single growth rate that applies everywhere. The most commonly tracked types are abdominal aortic aneurysms (AAA), thoracic aortic aneurysms (TAA), and intracranial (brain) aneurysms, and each has its own pace.

For abdominal aortic aneurysms, a large study using serial CT scans found a median growth rate of about 1.7 mm per year, with roughly two-thirds of aneurysms growing at a low rate and about a quarter growing faster than 2.5 mm annually. Growth accelerates as AAAs get bigger. In women with fusiform AAAs, for example, aneurysms under 3 cm grew at about 0.9 mm per year, while those at or above 5 cm grew at roughly 6 mm per year.

Thoracic aortic aneurysms tend to grow even more slowly, at least in the ascending aorta. A systematic review and meta-analysis found that ascending TAAs typically grow between 0.25 and 1 mm per year across various underlying causes. In fact, one study of ascending aneurysms below surgical threshold found an average growth rate of just 0.11 mm per year, with almost none showing clinically meaningful change during follow-up. Descending thoracic aneurysms are a different story. In the large ETTAA study, descending aortic aneurysms grew at about 2 mm per year, several times faster than those higher up.

Intracranial aneurysms are harder to pin down because most are small and many never change at all. A meta-analysis pooling nearly 5,000 brain aneurysms found that about 3% per aneurysm-year showed detectable growth. Population-level modeling estimated growth rates somewhere between 0.3 and 1.6 mm per year once growth begins, depending on the assumptions about rupture risk built into the model.

Growth Is Not Steady

One of the most important things to understand about aneurysm growth is that it rarely follows a smooth, predictable trajectory. If you imagine an aneurysm expanding like a balloon being slowly inflated, you have the wrong mental picture. Most aneurysms grow in fits and starts, or not at all for long stretches.

A study of abdominal aortic aneurysms in the 4 to 4.9 cm range found that nearly 9 in 10 expanded in a discontinuous pattern, meaning they would stay stable for a while and then jump in size. The minority that grew continuously had much faster overall expansion rates. A recent study of ascending aortic dilation found a similar breakdown: about half of patients were essentially stable over follow-up, roughly a fifth showed noise-like fluctuations without real growth, and about a quarter displayed episodic jumps. Among those who did grow meaningfully (2 mm or more total), the vast majority were in that episodic category, and over half had started with a normal-sized aorta.

This episodic behavior makes surveillance tricky. A single scan showing no change does not guarantee the aneurysm is dormant. It may simply be between growth spurts. Conversely, a single scan showing a size increase may not represent the start of a dangerous trend. Doctors rely on serial imaging over time to separate real growth from measurement noise and to catch those sudden jumps.

When Size Becomes Dangerous for Aortic Aneurysms

The traditional surgical repair thresholds for aortic aneurysms are rooted in an old cost-benefit calculation: repair carries risk, so you wait until the risk of rupture outweighs the risk of the operation. For decades, that threshold for AAA repair has been cited as 5.5 cm for men and 5.0 cm for women, but recent modeling suggests these numbers deserve a second look. A 2024 analysis found that for a 60-year-old woman in average health, the optimal repair threshold to minimize aneurysm-related death was about 6.1 cm, while for a 60-year-old man it was around 6.9 cm. The study also found that life expectancy barely changed across a wide range of repair sizes (within about two months), suggesting there is a broad “sweet spot” rather than a single magic number.

That does not mean everyone should wait until 6 or 7 cm. The optimal threshold shifts dramatically with a patient’s age, other health problems, and how fast the aneurysm is growing. A younger, healthy person with a fast-growing aneurysm may benefit from earlier repair, while an older person with serious comorbidities may do better with continued surveillance even at larger sizes. Rapid growth itself, regardless of current diameter, is often considered an independent reason to discuss intervention.

Brain Aneurysms and the Puzzle of Small-Aneurysm Rupture

Intracranial aneurysms play by somewhat different rules. Size still matters, but it is not the whole story, and some of the most alarming data concern small aneurysms. In one clinical series, about 62% of ruptured brain aneurysms were smaller than 7 mm, and at certain locations like the anterior communicating artery, small ruptured aneurysms were especially common. This does not mean small aneurysms are generally high-risk, since small unruptured aneurysms vastly outnumber large ones, but it does mean size alone is a poor predictor.

To capture the multiple factors that affect brain aneurysm rupture, researchers developed the PHASES risk score. This tool assigns points based on population background (Finnish and Japanese populations have higher risk), hypertension, age, aneurysm size, prior subarachnoid hemorrhage, and location. It has been validated in several studies and helps clinicians weigh the competing risks of treatment versus observation.

Growth itself is a strong danger signal for brain aneurysms. The meta-analysis of nearly 5,000 intracranial aneurysms found that those showing growth on imaging ruptured at a rate of about 3.1% per year, compared to just 0.1% per year for aneurysms that stayed stable. That thirty-fold difference makes growth detection arguably more important than any single diameter measurement.

What Drives an Aneurysm to Grow

Aneurysm enlargement is fundamentally a story about wall degradation. The artery wall is a layered structure containing proteins like collagen and elastin that give it strength and flexibility. When those structural proteins get broken down faster than the body can repair them, the wall weakens and stretches outward under blood pressure.

A key driver of this breakdown is inflammation. In aortic aneurysms, the density of inflammatory cells in the outer layer of the artery wall has been directly linked to aneurysm enlargement. These immune cells produce enzymes, particularly MMP-2 and MMP-9, that chew through structural proteins in the wall. Smaller aneurysms tend to show more MMP-2 activity, while larger, fast-growing ones shift toward MMP-9, suggesting the biology changes as the aneurysm progresses.

Blood flow patterns add another layer. The way blood moves through and around an aneurysm affects the forces on its wall. Regions exposed to abnormally low wall shear stress, where blood flow is sluggish or stagnant, tend to be where growth occurs. Low shear stress promotes damage to the inner lining of the blood vessel and triggers further inflammation. In brain aneurysms, elevated shear stress at the aneurysm neck and disrupted flow patterns within the sac work together to promote further enlargement. Small outpouchings called blebs, where the wall is thinnest, are where rupture most often happens and are strongly associated with these abnormal flow patterns.

Risk Factors That Speed Things Up

Smoking is the most discussed modifiable risk factor, though its role differs by aneurysm type. For abdominal aortic aneurysms, the evidence is clear. A network meta-analysis found that active smokers had AAA growth rates roughly 0.5 mm per year faster than non-smokers, and former smokers fell in between, growing about 0.45 mm per year slower than current smokers. At the tissue level, active smoking ramps up inflammation, oxidative stress, and new blood vessel formation throughout the aortic wall.

For brain aneurysms, the picture is less tidy. While smoking is an established risk factor for aneurysm formation and rupture, a meta-analysis specifically looking at observed growth of unruptured intracranial aneurysms did not find a statistically significant link between smoking and growth. This may reflect the difference between triggering formation or rupture and driving measurable enlargement, or it may simply reflect insufficient data.

High blood pressure is often assumed to be a major growth accelerator, but the evidence is surprisingly mixed. One study of infrarenal AAAs found no significant association between blood pressure control at enrollment and subsequent aneurysm growth. For thoracic aneurysms, however, the pulsatile quality of blood flow mattered more than the simple blood pressure reading. Stiffer arteries and higher pulse pressure, which means a larger difference between the peak and trough of each heartbeat, were independently linked to faster thoracic aneurysm growth. In other words, it is not just how high your blood pressure goes but how hard each pulse hammers the artery wall.

Sex Differences in Aneurysm Growth

Women and men do not experience aneurysm growth or rupture in the same way, and the discrepancy is large enough to matter clinically. In thoracic aortic aneurysms, a study found that women’s aneurysms grew at roughly twice the rate of men’s, about 1.2 mm per year versus 0.6 mm per year. This sex difference was driven by degenerative (non-heritable) aneurysms; among patients with genetic connective tissue disorders, the gap vanished.

The same theme shows up in brain aneurysms. The meta-analysis of intracranial aneurysm growth found that female sex was a significant risk factor, with about 3.2% of aneurysms showing growth per year in women versus 1.3% in men. In Marfan syndrome, where the aortic root is the primary concern, researchers have proposed reducing the surgical repair threshold for women by 5 mm because women experienced dissections at smaller diameters. These findings collectively suggest that using the same size thresholds for men and women likely leaves some women under-treated.

Genetic Conditions and Faster Growth

Connective tissue disorders substantially change the growth trajectory of aortic aneurysms. People with Marfan syndrome have defective fibrillin, a scaffolding protein in the artery wall, and their aortic root aneurysms grow at an estimated average of about 2.6 mm per year, with some reaching nearly 5 mm per year once the root exceeds 6 cm. The meta-analysis of thoracic aortic aneurysm growth across different conditions placed Marfan growth at about 0.45 mm per year and Loeys-Dietz syndrome, another connective tissue condition, at about 0.81 mm per year, though the confidence intervals for Loeys-Dietz were wide enough to signal uncertain data. The discrepancy between the Marfan-specific study and the meta-analysis likely reflects differences in the part of the aorta being measured and the patient populations included, but both sources agree that heritable conditions produce faster growth than sporadic aneurysms and justify earlier and more frequent surveillance.

People with bicuspid aortic valve, a common congenital heart defect affecting roughly 1 to 2% of the population, also tend to develop ascending aortic dilation. Their growth rate runs about 0.37 mm per year before any valve surgery, dropping to about 0.18 mm per year afterward, according to the same meta-analysis. This suggests that correcting the valve abnormality partly offsets the aortic risk, though ongoing monitoring remains standard practice.

Can Medication Slow Aneurysm Growth?

Despite decades of research, no drug has been convincingly proven to slow aortic aneurysm growth in large, well-controlled human trials. A comprehensive review in Circulation Research concluded that while some clinical studies have reported stabilization of growing aortic aneurysms, these findings are not consistently confirmed in larger controlled studies, and no medical therapy can be recommended for this purpose.

That said, several drug classes have shown enough biological plausibility or observational evidence to remain under investigation. Statins and certain antibiotics like doxycycline can reduce the activity of the MMPs that degrade the aortic wall, and both have shown some promise in animal models and observational studies. Blood pressure medications, including ACE inhibitors and angiotensin receptor blockers, have biological rationale and some observational support. But the gap between animal experiments and proven human benefit remains wide. For now, the standard medical advice centers on controlling cardiovascular risk factors (especially quitting smoking), managing blood pressure, and monitoring with imaging, while recognizing that these measures are not proven to directly slow wall expansion.

Why the Imaging Method Matters

A detail that surprises many patients is that an aneurysm’s measured size depends significantly on how it is measured. Ultrasound and CT scans do not produce the same numbers. In one study comparing the two, CT measurements were larger than ultrasound in 95% of cases, and the difference between the two exceeded 1 cm in nearly half of paired readings. Another study found that ultrasound measured about 4 mm smaller than CT on average, and that using a standardized measurement protocol narrowed the gap but could not eliminate it entirely.

This has practical consequences. If your first scan was an ultrasound and your follow-up is a CT, the aneurysm will appear to have grown even if it has not changed at all. Growth rates calculated from mixed imaging methods can be misleading. When you are tracking changes of just 1 or 2 mm per year, a built-in 4 mm measurement difference between modalities can completely obscure real trends or create phantom growth. This is why vascular guidelines stress consistent imaging: ideally, the same type of scan, the same measurement protocol, and if possible the same institution’s equipment over time.

For brain aneurysms, measuring growth is even harder because the aneurysms are smaller and oddly shaped. Traditional measurement reports a single maximum diameter, which can miss three-dimensional volume changes. A study using AI-assisted volumetric analysis found that all five aneurysms that eventually ruptured during conservative follow-up had shown growth, but two of those growth events were missed by standard manual diameter measurement. Volume increased by at least about 6% even when maximum diameter barely budged. Volumetric tracking is still mostly a research tool rather than standard clinical practice, but the study highlights a fundamental limitation of relying on a single diameter number for complex, irregularly shaped structures.

Headaches and Warning Signs

A common concern for people living with a known unruptured brain aneurysm is whether headaches signal impending rupture. This is understandable, since the classic “thunderclap headache” is the hallmark of an aneurysm that has already ruptured. But for unruptured aneurysms, the evidence does not currently support treating ordinary headaches as a warning sign of increased rupture risk. That distinction matters because unnecessary alarm over routine headaches can lead to anxiety-driven over-imaging or premature intervention, both of which carry their own risks.

There are, however, symptoms worth taking seriously. A sudden, unusually severe headache unlike anything you have experienced before, especially if accompanied by neck stiffness, vomiting, or loss of consciousness, requires emergency evaluation. For aortic aneurysms, sudden chest, back, or abdominal pain can signal rapid expansion or rupture. Aortic aneurysms are often called “silent” because they typically produce no symptoms until they are either very large or acutely expanding. That silence is precisely why screening and surveillance imaging exist: the aneurysm itself will not tell you it is growing.

Sudden blood pressure spikes from physical straining, vigorous exercise, or emotional stress can transiently increase pressure on an aneurysm wall. Research has documented that activities causing a rise in blood pressure can briefly alter blood flow patterns in the brain. Whether this translates to a meaningfully higher rupture risk during a specific activity remains difficult to quantify for any individual, but it is part of the rationale for managing blood pressure and avoiding extreme exertion in patients with known aneurysms at higher risk.

What Happens After Repair

Aneurysm treatment does not end with the procedure. Open surgical repair replaces or reinforces the weakened vessel segment, and for most patients the repaired segment itself is not expected to re-enlarge. Endovascular repair, which uses a stent-graft threaded through the arteries to line the aneurysm from inside, has its own long-term concern: endoleaks. These are situations where blood continues to flow into the aneurysm sac around or through the stent-graft, and they occur in up to about a quarter of patients. Some endoleaks are benign and seal on their own; others can cause the aneurysm sac to re-pressurize and continue growing, potentially requiring additional intervention. Lifelong imaging follow-up is standard after endovascular repair for this reason, though the intervals often lengthen over time if scans remain clean.